|  | SHPF group (n = 22) | VHPF group (n = 22) | P value |
---|---|---|---|---|
Incidence of gastrointestinal tolerance parametersa | ||||
 Diarrhea | n (%) | 11 (50.0%) | 8 (36.4%) | 0.361b |
 Constipation | n (%) | 16 (72.7%) | 13 (59.1%) | 0.340b |
 High gastric residual volume (> 500 ml) | n (%) | 5 (22.7%) | 4 (18.2%) | 0.567c |
 Vomiting | n (%) | 6 (27.3%) | 5 (22.7%) | 1.000d |
Clinical outcome parameters | ||||
Mortality rate | ||||
  Total 28 days | n (%) | 3 (13.6%) | 2 (9.1%) | 0.560e |
  Total 42 days | n (%) | 3 (13.6%) | 3 (13.6%) | 0.886e |
  Hospital | n (%) | 3 (13.6%) | 2 (9.1%) | 0.638c |
  ICU | n (%) | 2 (9.1%) | 1 (4.5%) | 0.637c |
Duration of ICU stay (day) | mean (SD) | 18.3 (12.7) | 18.4 (13.4) | 0.913f |
 | 95% CI | 12.7–23.9 | 12.4–24.3 |  |
Duration of hospital stay (day) | Mean (SD) | 28.2 (13.2) | 28.5 (13.3) | 0.955f |
 | 95% CI | 22.4–34.1 | 22.5–34.4 |  |
Duration of first ventilation period (day) | Mean (SD) | 7.4 (5.4) | 10.0 (8.7) | 0.234f |
 | 95% CI | 5.0–9.8 | 6.1–13.9 |  |
SOFA scores | ||||
 Screening | median [IQR] | 9 [7–11] | 10 [9–11] | 0.514g |
 Day 5 | Median [IQR] | 6 [4–8] | 6 [3–8] | 0.647g |
 Day 10 | Median [IQR] | 5 [4–9] | 4 [1–7] | 0.432g |
 End of study | Median [IQR] | 2 [1–3] | 2 [1–3] | 0.608g |
 Day 28 | Median [IQR] | 1 [0–2] | 3 [2–3] | 0.446g |